| 000 | 01849 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515170742.0 | ||
| 264 | 0 | _c20090715 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1476-5586 | ||
| 024 | 7 |
_a10.1593/neo.81526 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLe Mercier, Marie | |
| 245 | 0 | 0 |
_aGalectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. _h[electronic resource] |
| 260 |
_bNeoplasia (New York, N.Y.) _cMay 2009 |
||
| 300 |
_a485-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xphysiology |
| 650 | 0 | 4 |
_aGalectin 1 _xmetabolism |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xgenetics |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeurogenesis _xphysiology |
| 650 | 0 | 4 |
_aOligodendroglioma _xgenetics |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aFortin, Shannon | |
| 700 | 1 | _aMathieu, Véronique | |
| 700 | 1 | _aRoland, Isabelle | |
| 700 | 1 | _aSpiegl-Kreinecker, Sabine | |
| 700 | 1 | _aHaibe-Kains, Benjamin | |
| 700 | 1 | _aBontempi, Gianluca | |
| 700 | 1 | _aDecaestecker, Christine | |
| 700 | 1 | _aBerger, Walter | |
| 700 | 1 | _aLefranc, Florence | |
| 700 | 1 | _aKiss, Robert | |
| 773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 11 _gno. 5 _gp. 485-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.81526 _zAvailable from publisher's website |
| 999 |
_c18841537 _d18841537 |
||